Company: ARWR
Filing Date: 2025-01-29
Form Type: DEF 14A
Source: 0001628280-25-002848
Chunk: 54

Company: ARROWHEAD PHARMACEUTICALS, INC.
Filing Date: 2025-01-29
Form: DEF 14A
Chunk 54
---
 as a group, each as computed in accordance with Item 402(v) of Regulation S-K and do not reflect the total compensation actually realized or received by Christopher Anzalone or the other NEOs on average, as applicable. In accordance with these rules, these amounts reflect “Total Compensation” as set forth in the Summary Compensation Table for each year, adjusted as shown below. Equity values are calculated in accordance with FASB ASC Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant.

| 53 |

2025 PROXY STATEMENT

| Compensation Actually Paid                                                                                                                            |     | 2024 
 PEO  |             |     | Other NEOs* |            |     | 2023 
 PEO  |             |     | Other NEOs* |            |     | 2022 
 PEO  |             |     | Other NEOs* |            |     | 2021 
 PEO  |             |     | Other NEOs* |            |
|:------------------------------------------------------------------------------------------------------------------------------------------------------|:----|:-----|------------:|:----|:------------|-----------:|:----|:-----|------------:|:----|:------------|-----------:|:----|:-----|------------:|:----|:------------|-----------:|:----|:-----|------------:|:----|:------------|-----------:|
| Summary Compensation Table Total                                                                                                                      |     | $    |  12,423,473 |     | $           |  3,493,347 |     | $    |   9,918,093 |     | $           |  3,143,102 |     | $    |  12,031,969 |     | $           |  4,133,800 |     | $    |  24,703,855 |     | $           |  3,324,746 |
| Less, value of “Stock Awards” and “Option Awards” reported in Summary Compensation Table                                                              |     | $    | -10,319,000 |     | $           | -2,658,810 |     | $    |  -8,314,056 |     | $           | -2,332,400 |     | $    | -10,382,549 |     | $           | -3,529,925 |     | $    | -23,019,000 |